C3 glomerulopathy

You have accessRestricted Access
Large-Scale Whole-Genome Sequencing Reveals the Genetic Architecture of Primary Membranoproliferative GN and C3 Glomerulopathy
Adam P. Levine, Melanie M.Y. Chan, Omid Sadeghi-Alavijeh, Edwin K.S. Wong, H. Terence Cook, Sofie Ashford, Keren Carss, Martin T. Christian, Matthew Hall, Claire Louise Harris, Paul McAlinden, Kevin J. Marchbank, Stephen D. Marks, Heather Maxwell, Karyn Megy, Christopher J. Penkett, Monika Mozere, Kathleen E. Stirrups, Salih Tuna, Julie Wessels, Deborah Whitehorn, MPGN/DDD/C3 Glomerulopathy Rare Disease Group, NIHR BioResource, Sally A. Johnson and Daniel P. Gale

JASN January 2020, ASN.2019040433; DOI: https://doi.org/10.1681/ASN.2019040433

Add to Selected Citations
You have accessRestricted Access
The MFHR1 Fusion Protein Is a Novel Synthetic Multitarget Complement Inhibitor with Therapeutic Potential
Stefan Michelfelder, Friedericke Fischer, Astrid Wäldin, Kim V. Hörle, Martin Pohl, Juliana Parsons, Ralf Reski, Eva L. Decker, Peter F. Zipfel, Christine Skerka and Karsten Häffner

JASN April 2018, 29 (4) 1141-1153; DOI: https://doi.org/10.1681/ASN.2017070738

Add to Selected Citations
You have accessRestricted Access
Cluster Analysis Identifies Distinct Pathogenetic Patterns in C3 Glomerulopathies/Immune Complex–Mediated Membranoproliferative GN
Paraskevas Iatropoulos, Erica Daina, Manuela Curreri, Rossella Piras, Elisabetta Valoti, Caterina Mele, Elena Bresin, Sara Gamba, Marta Alberti, Matteo Breno, Annalisa Perna, Serena Bettoni, Ettore Sabadini, Luisa Murer, Marina Vivarelli, Marina Noris and Giuseppe Remuzzi; for the Registry of Membranoproliferative Glomerulonephritis/C3 Glomerulopathy

JASN January 2018, 29 (1) 283-294; DOI: https://doi.org/10.1681/ASN.2017030258

Add to Selected Citations
You have accessRestricted Access
Clusters Not Classifications: Making Sense of Complement-Mediated Kidney Injury
H. Terence Cook and Matthew C. Pickering

JASN January 2018, 29 (1) 9-12; DOI: https://doi.org/10.1681/ASN.2017111183

Add to Selected Citations
You have accessRestricted Access
Moss-Produced, Glycosylation-Optimized Human Factor H for Therapeutic Application in Complement Disorders
Stefan Michelfelder, Juliana Parsons, Lennard L. Bohlender, Sebastian N.W. Hoernstein, Holger Niederkrüger, Andreas Busch, Nicola Krieghoff, Jonas Koch, Benjamin Fode, Andreas Schaaf, Thomas Frischmuth, Martin Pohl, Peter F. Zipfel, Ralf Reski, Eva L. Decker and Karsten Häffner

JASN May 2017, 28 (5) 1462-1474; DOI: https://doi.org/10.1681/ASN.2015070745

Add to Selected Citations
You have accessRestricted Access
High-Throughput Genetic Testing for Thrombotic Microangiopathies and C3 Glomerulopathies
Fengxiao Bu, Nicolo Ghiringhelli Borsa, Michael B. Jones, Erika Takanami, Carla Nishimura, Jill J. Hauer, Hela Azaiez, Elizabeth A. Black-Ziegelbein, Nicole C. Meyer, Diana L. Kolbe, Yingyue Li, Kathy Frees, Michael J. Schnieders, Christie Thomas, Carla Nester and Richard J.H. Smith

JASN April 2016, 27 (4) 1245-1253; DOI: https://doi.org/10.1681/ASN.2015040385

Add to Selected Citations
You have accessRestricted Access
Dense Deposit Disease Mimicking a Renal Small Vessel Vasculitis
Lavleen Singh, Geetika Singh, Swati Bhardwaj, Aditi Sinha, Arvind Bagga and Amit Dinda

JASN January 2016, 27 (1) 59-62; DOI: https://doi.org/10.1681/ASN.2015020187

Add to Selected Citations

Main menu

User menu

Search

C3 glomerulopathy

About

Author Information

More Information